Drug-resistant gonorrhoea on the rise in Europe, ECDC warns
The European Centre for Disease Prevention and Control (ECDC) has warned of an increase in ceftriaxone-resistant gonorrhoea across Europe. The rise in these resistant strains poses a significant challenge for the treatment of the sexually transmitted infection.
An increasing number of European countries have detected gonococcal strains resistant to the antibiotic ceftriaxone, the first-line drug to treat gonorrhoea infection. Alongside growing evidence of the domestic spread of such resistant strains in Europe over the last two years, this poses a significant challenge for future treatment options for one of the most common sexually transmitted diseases worldwide, according to an assessment issued by the European Centre for Disease Prevention and Control (ECDC).
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in